Mirabaud Asset Management
ABBV icon

Mirabaud Asset Management’s AbbVie ABBV Stock Holding History

Mirabaud Asset Management’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		– Sell
-11,588
Closed -$2.97M – 27
2026
Q2 		$2.95M Sell
11,588
-13,457
-54% -$2.9M 2.45% 13
2026
Q1 		$5.34M Buy
25,045
+9,636
+63% +$2.14M 4.4% 11
2025
Q4 		$2.96M Buy
15,409
+5,131
+50% +$1.17M 1.37% 25
2025
Q3 		$2.29M Sell
10,278
-1,054
-9% -$215K 1.11% 25
2025
Q2 		$2.07M Sell
11,332
-668
-6% -$124K 0.96% 27
2025
Q1 		$2.46M Sell
12,000
-4,801
-29% -$933K 1.29% 26
2024
Q4 		$2.96M Hold
16,801
– – 1.38% 23
2024
Q3 		$3.27M Buy
16,801
+7,726
+85% +$1.44M 1.35% 28
2024
Q2 		$1.56M Sell
9,075
-110
-1% -$18.2K 0.72% 34
2024
Q1 		$1.67M Buy
+9,185
New +$1.58M 0.68% 32

Other funds holding ABBV

State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.84T AUM 33.86% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $704B AUM 26.74% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $474B AUM 32.39% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $824B AUM 37.44% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $483B AUM 27.72% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return

Mirabaud Asset Management's ABBV Position: Q3 2026 in Review

Mirabaud Asset Management sold out of AbbVie (ABBV) in Q3 2026, closing a stake of 11,588 shares — an estimated $2.97M sold.

Mirabaud Asset Management first reported a position in ABBV in Q1 2024 and held it in 10 quarters. The position peaked at $5.34M in Q1 2026. 3,450 funds tracked by Wall St. Rank hold ABBV as of Q3 2026.

  • Mirabaud Asset Management reported no remaining AbbVie position as of Q3 2026 after selling out during the quarter.
  • Mirabaud Asset Management sold 11,588 AbbVie shares in Q3 2026, an estimated $2.97M.
  • Mirabaud Asset Management first reported a position in AbbVie in Q1 2024 and held it in 10 quarters.
  • Mirabaud Asset Management's AbbVie position peaked at $5.34M in Q1 2026.
  • 3,450 funds tracked by Wall St. Rank held AbbVie as of Q3 2026.

Based on Mirabaud Asset Management's 13F filing for Q3 2026, filed 9 Nov 2026.